法国创新型初创公司Bioptimus近期在生物科学领域引发关注，成功完成了3500万美元的种子轮融资。这家致力于构建大型语言模型以推动生物技术发展的AI企业，自成立以来仅数月便吸引了众多投资者的目光。本轮融资由知名生命科学风投Sofinnova Partners和法国公共银行Bpifrance Large Ventures共同领投，显示了业界对Bioptimus前景的高度期待。
此外，本次融资还获得了法国风险投资公司Frst、全球投资机构Cathay Innovation，以及来自美国的投资者Headline和Owkin的积极参与。值得一提的是，法国亿万富翁企业家Xavier Niel也加入了投资者行列，他的加入无疑为Bioptimus的未来发展注入了更强的信心。
Bioptimus的创新理念和潜在的生物技术应用，已经成功吸引了全球范围内的投资者，预示着AI在生物科学领域的应用可能即将迎来新的突破。随着这笔资金的注入，Bioptimus有望加速其研发进程，为生物技术行业带来颠覆性的变革。
英语如下：
News Title: “Bioptimus, a Startup, Raises $35M Seed Funding, Sparking AI-driven Bioscience Boom”
Keywords: Bioptimus, seed funding, $35 million
News Content:
Up-and-coming AI-driven bioscience star Bioptimus has grabbed headlines with a $35 million seed funding round, poised to revolutionize the biotech sector. The French startup, focused on developing large language models to advance biotechnology, has attracted significant investor attention in just a few months since its inception. This round was co-led by prominent life sciences venture capitalist Sofinnova Partners and French public bank Bpifrance Large Ventures, reflecting high industry expectations for the company.
Notably, the funding was also joined by French VC firm Frst, global investor Cathay Innovation, and US-based investors Headline and Owkin. Adding to the investor lineup is French billionaire entrepreneur Xavier Niel, whose involvement signals strong confidence in Bioptimus’s future prospects.
Bioptimus’s innovative approach and potential applications in biotechnology have piqued the interest of global investors, suggesting a new wave of breakthroughs in AI integration within the field. With this influx of capital, the company is well-positioned to hasten its research and development, potentially disrupting the biotech industry with transformative changes.
【来源】https://sifted.eu/articles/bioptimus-owkin-35m-seed
Views: 1